http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110772633-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2518b2ae6a83d7bb8ecad4ac511ba6e3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-481
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004
filingDate 2019-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_108239270fac4f79e6c6a314075605f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f573dc7c465e15664e5471ce5dc21cba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b84aacdd25e779f326d362939391cd61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4530c4b6a3e7b9adee199991ec53649
publicationDate 2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110772633-A
titleOfInvention A kind of composition for treating intestinal mucosa and preparation method thereof
abstract The invention discloses a composition for treating intestinal mucosa and a preparation method thereof, comprising laminin, fibronectin, serum protein, small molecule active peptide, Atractylodes monosaccharide and astragalus saponin. The medicinal materials selected in the present invention are intestinal therapeutic products prepared according to the technical requirements for the preparation of biological products, which contain laminin, fibronectin, serum protein, small molecule active peptides, Atractylodes monosaccharide and astragalus saponins. The compatibility relationship and the complementarity of the active ingredients in each medicinal material, while laminin not only plays the role of neurotrophic factor in the process of peripheral nerve regeneration, but also plays a guiding role in the direction of nerve growth. Compared with the present invention, the drug action mechanism of the present invention is more scientific, the curative effect is good, the side effect is small, and the cost is low.
priorityDate 2019-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45006101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID362572
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID265785
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11876
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426274158
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID265785

Total number of triples: 31.